These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
96 related articles for article (PubMed ID: 1478213)
1. The influence of clinical intervention on pressure-volume relationships--the conductance (volume) technique. Thormann J Eur Heart J; 1992 Nov; 13 Suppl E():69-79. PubMed ID: 1478213 [TBL] [Abstract][Full Text] [Related]
2. Proof for piroximone's inotropic influence; can it safely be used in coronary artery disease? Analysis of end-systolic pressure-volume relations (conductance technique). Thormann J; Liebrich A; Mitrovic V; Strasser R; Dieterich HA; Schlepper M J Cardiovasc Pharmacol; 1992 Jul; 20(1):50-62. PubMed ID: 1383631 [TBL] [Abstract][Full Text] [Related]
3. [Effect of the class IA anti-arrhythmic agents ajmaline on end-systolic pressure-volume relations (conductance technique)]. Thormann J; Hüting J; Kremer P; Mitrovic V; Wissemann J; Bahawar H; Schlepper M Z Kardiol; 1990 Oct; 79(10):706-16. PubMed ID: 2087858 [TBL] [Abstract][Full Text] [Related]
4. Do class 1 antiarrhythmic drugs impair myocardial contractility? The class 1A example of ajmaline (conductance catheter technique). Thormann J; Hüting J; Kremer P; Wissemann J; Bahawar H; Schlepper M J Cardiovasc Pharmacol; 1990 Aug; 16(2):182-90. PubMed ID: 1697372 [TBL] [Abstract][Full Text] [Related]
5. Enoximone: true inotropic effects? Do they cause ischemia? Analysis of end-systolic pressure-volume relations using the conductance (volume) catheter technique. Thormann J; Hueting J; Kremer P; Wissemann J; Mitrovic V; Dieterich HA; Schlepper M Cardiovasc Drugs Ther; 1990 Oct; 4(5):1403-15. PubMed ID: 2149060 [TBL] [Abstract][Full Text] [Related]
6. [Is the bradycardic effect of tedisamil at the expense of the loss of the inotropic effect? A pressure-volume analysis with the conductance (volume) catheter technique in patients with coronary artery disease]. Thormann J; Mitrovic V; Strasser R; Pitschner HF; Riedel H; Bahavar H; Schlepper M Z Kardiol; 1993 Apr; 82(4):211-21. PubMed ID: 8506715 [TBL] [Abstract][Full Text] [Related]
7. Effects of intracoronary infusion of an inotropic agent, E-1020 (loprinone hydrochloride), on cardiac function: evaluation of left ventricular contractile performance using the end-systolic pressure-volume relationship. Murakami R; Sano K; Murakami Y; Shimada T; Morioka S Int J Cardiol; 1995 Aug; 51(1):57-63. PubMed ID: 8522398 [TBL] [Abstract][Full Text] [Related]
8. Left ventricular filling after long-term angiotensin converting enzyme inhibition in congestive heart failure. Baur LH; Schipperheyn JJ; Cats VM; van der Wall EE; Baan J; van Dijk AD; Bruschke AV Eur Heart J; 1992 Nov; 13 Suppl E():52-6. PubMed ID: 1478210 [TBL] [Abstract][Full Text] [Related]
9. Comparison between the positive inotropic effects of enoximone, a cardiac phosphodiesterase III inhibitor, and dobutamine in patients with moderate to severe congestive heart failure. A study using the end-systolic pressure-volume relationship method. Installe E; De Coster P; Gonzalez M; Brichant C; Lessire H; Cauwe F Eur Heart J; 1991 Sep; 12(9):985-93. PubMed ID: 1834466 [TBL] [Abstract][Full Text] [Related]
10. Continuous measurement of the pressure-volume relationship in experimental heart failure produced by rapid ventricular pacing in conscious dogs. Sasayama S; Asanoi H; Ishizaka S Eur Heart J; 1992 Nov; 13 Suppl E():47-51. PubMed ID: 1478209 [TBL] [Abstract][Full Text] [Related]
11. Comparison between preload recruitable stroke work and the end-systolic pressure-volume relationship in man. Takeuchi M; Odake M; Takaoka H; Hayashi Y; Yokoyama M Eur Heart J; 1992 Nov; 13 Suppl E():80-4. PubMed ID: 1478215 [TBL] [Abstract][Full Text] [Related]
12. Evaluation of the inotropic function at rest and the effect of enoximone in heart transplanted recipients. Assessment by left ventricular endsystolic pressure volume relationship. Heublein B; Auricchio A; Wagenbreth I; Haverich A; Dieterich HA J Cardiovasc Surg (Torino); 1992; 33(1):21-7. PubMed ID: 1531987 [TBL] [Abstract][Full Text] [Related]
13. [Pharmacologic myocardial protection during percutaneous transluminal coronary angioplasty (PTCA) by intracoronary dipyridamole: hemodynamic, contractile and dynamic ventricular consequences]. Strauer BE; Heidland UE; Heintzen MP; Schwartzkopff B Z Kardiol; 1995 Nov; 84(11):898-910. PubMed ID: 8571641 [TBL] [Abstract][Full Text] [Related]
14. [Use of enoximone in patients with acute and subacute heart failure in the intensive care unit]. Holubarsch C; Pieske B; Hasenfuss G; Just H Z Kardiol; 1994; 83 Suppl 2():21-5. PubMed ID: 8091821 [TBL] [Abstract][Full Text] [Related]
15. [Determination of active components of amrinone by analysis of pressure-volume results; use of the conductance (volume) catheter technic and rapid load change by balloon occlusion of the inferior vena cava]. Thormann J; Kramer W; Kindler M; Kremer P; Schlepper M Z Kardiol; 1987 Sep; 76(9):530-40. PubMed ID: 3424908 [TBL] [Abstract][Full Text] [Related]
16. [The information value of the left ventricular end-systolic volume-pressure ratio for the noninvasive assessment of human cardiac contractile function]. Kostyliev MV; Hryhorash HA; Moĭbenko OO Fiziol Zh (1994); 1994; 40(5-6):57-63. PubMed ID: 8521992 [TBL] [Abstract][Full Text] [Related]
17. Relevance of the volume-axis intercept, V0, compared with the slope of end-systolic pressure-volume relationship in response to large variations in inotropy and afterload in rats. Blaudszun G; Morel DR Exp Physiol; 2011 Nov; 96(11):1179-95. PubMed ID: 21890525 [TBL] [Abstract][Full Text] [Related]
18. The end-systolic pressure-volume relationship in young animals using the conductance technique. Teitel DF; Klautz RJ; Cassidy SC; Steendijk P; van der Velde ET; van Bel F; Baan J Eur Heart J; 1992 Nov; 13 Suppl E():40-6. PubMed ID: 1478208 [TBL] [Abstract][Full Text] [Related]
19. Effects of changes in left ventricular contractility on indexes of contractility in mice. Nemoto S; DeFreitas G; Mann DL; Carabello BA Am J Physiol Heart Circ Physiol; 2002 Dec; 283(6):H2504-10. PubMed ID: 12427596 [TBL] [Abstract][Full Text] [Related]
20. [Effects of the phosphodiesterase III inhibitor in ischemic heart disease]. Schlepper M; Mitrovic V; Thormann J Z Kardiol; 1991; 80 Suppl 4():75-83. PubMed ID: 1926997 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]